Cutler Group’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-80
Closed -$1K 6035
2021
Q3
$1K Hold
80
﹤0.01% 5434
2021
Q2
$1K Sell
80
-20
-20% -$3.91K ﹤0.01% 5426
2021
Q1
$1K Buy
+100
New +$23.7K ﹤0.01% 5371

Other funds holding STRO

Cutler Group's STRO Position: Q2 2022 in Review

Cutler Group sold out of Sutro Biopharma (STRO) in Q2 2022, closing a stake of 56 shares — an estimated $4K sold.

Cutler Group first reported a position in STRO in Q1 2021 and held it in 5 quarters. The position peaked at $81K in Q1 2021. 114 funds tracked by Wall St. Rank hold STRO as of Q2 2022.

  • Cutler Group reported no remaining Sutro Biopharma position as of Q2 2022 after selling out during the quarter.
  • Cutler Group sold 56 Sutro Biopharma shares in Q2 2022, an estimated $4K.
  • Cutler Group first reported a position in Sutro Biopharma in Q1 2021 and held it in 5 quarters.
  • Cutler Group's Sutro Biopharma position peaked at $81K in Q1 2021.
  • 114 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.